Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cosciens Biopharma Inc (CSCIF)

Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cosciens Biopharma Inc 222 BAY STREET SUITE 3000 PO BOX 53 TORONTO A6 M5K 1E7 CAN

www.cosciensbio.com Employees: 40 P: 843-900-3223

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

COSCIENS Biopharma Inc. is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. COSCIENS Biopharma Inc., formerly known as Aeterna Zentaris Inc., is based in TORONTO, ONTARIO.

Key Statistics

Overview:

Market Capitalization, $K 6,907
Enterprise Value, $K -9,483
Shares Outstanding, K 3,183
Annual Sales, $ 9,590 K
Annual Net Income, $ -15,310 K
Last Quarter Sales, $ 1,480 K
Last Quarter Net Income, $ -1,820 K
EBIT, $ -7,610 K
EBITDA, $ -6,860 K
60-Month Beta 0.61
% of Insider Shareholders 0.10%
% of Institutional Shareholders 0.73%
Float, K 3,180
% Float 99.90%
Short Interest 4
Short Float 0.12%
Short Volume Ratio 0.04

Growth:

1-Year Return -22.36%
3-Year Return -83.18%
5-Year Return -94.64%
5-Year Revenue Growth 1,709.43%
5-Year Earnings Growth 88.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.57 on 11/11/25
Next Earnings Date 04/08/26
Earnings Per Share ttm -4.73
EPS Growth vs. Prev Qtr 32.94%
EPS Growth vs. Prev Year 69.19%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 05/03/24

CSCIF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -168.04%
Return-on-Assets % -50.69%
Profit Margin % -159.65%
Debt/Equity 0.00
Price/Sales 0.72
Price/Cash Flow N/A
Price/Book 1.39
Book Value/Share 1.56
Interest Coverage -116.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar